PlexusDx Precision Peptide Genetic Test identifies variants in inflammation-related pathways and GLP-1 receptor responsiveness, helping personalize your semaglutide therapy
As described above, the STENO-2 trial demonstrated that intensive control of multiple risk factors, including not only glycaemic, BP and lipid management but also the use of antiplatelet therapy in primary prevention and treatment of albuminuria with blockers of the reninangiotensin system, reduces microvascular and macrovascular diabetes complications and potentially mortality risk [1, 2]
Frequently asked questions What is the most common side effect of cagrilintide
The same principles that guide semaglutide dosing escalation apply regardless of delivery format
Healthcare (Basel, Switzerland), 12 (22), 2263
So maybe try to start it when your schedule is clear, if that ever happens